Big Move For Applied Therapeutics, Inc.

Applied Therapeutics, Inc. (APLT:NASDAQ) rocketted at $35.18, a gain of 34.5%. The stock appeared on our News Catalysts scanner on Wed 08 Jan 20 at 11:50 AM in the 'RECOMMENDATION' category. From Mon 16 Dec 19, the stock recorded 57.14% Up Days and 66.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About Applied Therapeutics, Inc. (APLT:NASDAQ)

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.